A detailed history of Pier 88 Investment Partners LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 4,690 shares of NBIX stock, worth $519,417. This represents 0.85% of its overall portfolio holdings.

Number of Shares
4,690
Previous 3,090 51.78%
Holding current value
$519,417
Previous $355,000 80.28%
% of portfolio
0.85%
Previous 0.47%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$111.62 - $139.44 $178,592 - $223,104
1,600 Added 51.78%
4,690 $640,000
Q3 2024

Nov 05, 2024

SELL
$114.58 - $153.15 $52,706 - $70,449
-460 Reduced 12.96%
3,090 $355,000
Q2 2024

Aug 06, 2024

BUY
$130.86 - $143.19 $274,806 - $300,699
2,100 Added 144.83%
3,550 $488,000
Q1 2024

May 10, 2024

BUY
$130.4 - $143.74 $189,080 - $208,423
1,450 New
1,450 $199,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.6B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Pier 88 Investment Partners LLC Portfolio

Follow Pier 88 Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.